Reader in Critical and Social Psychiatry, Division of Psychiatry,University College London,London,UK.
Epidemiol Psychiatr Sci. 2018 Apr;27(2):133-140. doi: 10.1017/S2045796017000555. Epub 2017 Oct 12.
This article explores an alternative understanding of how psychiatric drugs work that is referred to as the drug-centred model of drug action. Unlike the current disease-centred model, which suggests that psychiatric drugs work by correcting an underlying brain abnormality, the drug-centred model emphasises how psychiatric drugs affect mental states and behaviour by modifying normal brain processes. The alterations produced may impact on the emotional and behavioural problems that constitute the symptoms of mental disorders.
Arguments are put forward that justify the consideration of the drug-centred model. The research necessary to support the prescription of drugs according to such a model is explored.
Evidence from neurochemistry and comparative drug trials do not confirm the disease-centred model of drug action. Since psychiatric drugs are recognised to have mind- and behaviour-altering properties, the drug-centred model constitutes a plausible alternative. The drug-centred model suggests that research is needed to identify all the alterations produced by various sorts of drugs, both acute and long term, and how these might interact with the symptoms and problems associated with different mental disorders. This requires detailed animal and volunteer studies and data from patients prescribed drug treatment long term, along with placebo-controlled and comparative trials that look at the overall impact of drug-induced alterations on well-being and functioning as well as symptoms. Research is also needed on alternative ways of fulfilling the function of drug treatment. The moral aspect of using drugs to modify behaviour rather than treat disease needs honest and transparent consideration.
It is hoped this discussion will encourage the psychiatric and pharmaceutical research community to provide more of the information that is required to use psychiatric drugs safely and effectively.
本文探讨了一种对精神科药物作用机制的另类理解,即药物中心模型。与当前以疾病为中心的模型不同,后者认为精神科药物通过纠正潜在的大脑异常起作用,而药物中心模型则强调精神科药物如何通过改变正常的大脑过程来影响精神状态和行为。所产生的改变可能会影响构成精神障碍症状的情绪和行为问题。
提出了支持考虑药物中心模型的论据。探讨了支持根据这种模型开处方的研究。
神经化学和比较药物试验的证据并不证实以疾病为中心的药物作用模型。由于精神科药物被认为具有改变思维和行为的特性,因此药物中心模型构成了一种合理的替代方案。药物中心模型表明,需要进行研究以确定各种药物(包括急性和长期)产生的所有改变,以及这些改变如何与不同精神障碍相关的症状和问题相互作用。这需要详细的动物和志愿者研究以及长期接受药物治疗的患者的数据,以及安慰剂对照和比较试验,以观察药物诱导的改变对幸福感和功能以及症状的总体影响。还需要研究替代方法来实现药物治疗的功能。使用药物来改变行为而不是治疗疾病的道德方面需要诚实和透明的考虑。
希望本文的讨论将鼓励精神科和制药研究界提供更多安全有效使用精神科药物所需的信息。